amifostine anhydrous has been researched along with Osteoradionecrosis in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Osteoradionecrosis: Necrosis of bone following radiation injury.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Page, EE | 1 |
Deshpande, SS | 3 |
Nelson, NS | 2 |
Felice, PA | 2 |
Donneys, A | 2 |
Rodriguez, JJ | 1 |
Buchman, SR | 2 |
Gong, B | 1 |
Ahsan, S | 1 |
Tchanque-Fossuo, C | 1 |
Morris, MD | 1 |
2 other studies available for amifostine anhydrous and Osteoradionecrosis
Article | Year |
---|---|
Prophylactic administration of Amifostine protects vessel thickness in the setting of irradiated bone.
Topics: Amifostine; Analysis of Variance; Animals; Dose Fractionation, Radiation; Dose-Response Relationship | 2015 |
Raman spectroscopy delineates radiation-induced injury and partial rescue by amifostine in bone: a murine mandibular model.
Topics: Amifostine; Animals; Collagen; Male; Mandible; Osteoradionecrosis; Rats; Rats, Sprague-Dawley; Spect | 2015 |